Own NIB shares? Here are the key dates for 2026

NIB has released its corporate calendar, including dividend dates, for 2026.

| More on:
A little boy, soon to be a brother, kisses and holds his mum's pregnant tummy.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Australians are facing rising premiums for private health insurance with fewer benefits, as highlighted by the AMA's 2025 report which criticises insurers for delivering poor value despite strong profits.
  • NIB Holdings reported increased revenue in FY25, but with a decrease in group underlying profit, although net profit after tax grew by 9.4%.
  • In 2026, important NIB investor dates include announcements for half-year results and dividends on 23 February and full-year results on 24 August, with dividends scheduled for April and October.

The NIB Holdings Ltd (ASX: NHF) share price is down 2.47% to $6.71 on Friday.

A scathing new report shows Australians are paying more for private health insurance policies but receiving fewer benefits.

The key benefits of private health insurance include help with costs, the ability to choose your doctor, shorter waiting periods for elective surgery, and a tax break for higher income earners, as having insurance means they don't have to pay the Medicare surcharge.

The Australian Medical Association (AMA) released its 2025 Private Health Insurance Report Card today.

The report shows consumers are feeling increasingly dissatisfied with the value for money they're getting while insurers post big profits.

For FY25, NIB reported higher revenue, lower underlying group profit, and higher net profit after tax (NPAT).

Revenue was $3.6 billion in FY25, up from $3.3 billion in FY24. Group underlying operating profit was $239.2 million, down from $257.5 million in FY24, and NPAT was $198.6 million, up 9.4% from $181.6 million in FY24.

What did the AMA say about private health insurance?

AMA President Dr Danielle McMullen said the report "reveals a system increasingly failing to deliver value for money".

Dr McMullen said:

Premiums have risen sharply, outpacing inflation, wage growth, and Medicare indexation — while coverage has narrowed.

Sixty-eight per cent of hospital policies now contain exclusions, meaning many Australians are paying more, but are covered for less.

The report found that Australian consumers were dropping gold level policies in favour of cheaper silver and bronze packages.

Since March 2020, the number of gold health insurance policies has fallen by 360,000 while the overall number of policies has risen 640,000.

Dr McMullen commented:

The tiered product system introduced in 2020 — basic, bronze, silver, and gold — was designed to simplify choices but has instead created confusion and contributed to underinsurance.

Gold-tier policies, which provide the most comprehensive coverage, are particularly susceptible to phoenixing — a term used when insurers close an existing policy and replace it with a nearly identical one at a higher price — a practice that has become increasingly common.

Key dates for NIB shares investors in 2026

Looking ahead to 2026, here are the important dates for NIB shares investors to note.

NIB will announce its FY26 half-year results and interim dividend on 23 February.

The ex-dividend date for the interim NIB dividend will be 5 March.

If you'd like NIB to use your dividends to reinvest in more shares, you'll need to enrol in the dividend reinvestment plan (DRP) by 9 March.

NIB shareholders will receive their dividends on 8 April.

The private health insurer will announce its FY26 full-year results and final dividend on 24 August.

The ex-dividend date for the final NIB dividend will be 3 September.

The DRP deadline will be 7 September.

NIB will pay its shareholders on 7 October.

The insurer will hold its annual general meeting on 11 November.

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended NIB Holdings. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Female scientist working in a laboratory.
Healthcare Shares

Early success in battling Crohn's Disease has sent this ASX biotech's shares soaring

The early-stage results have been described as outstanding.

Read more »

Medical workers examine an xray or scan in a hospital laboratory.
Healthcare Shares

Why are 4DMedical shares in a trading halt today?

The company is looking to raise fresh capital.

Read more »

Medical workers examine an xray or scan in a hospital laboratory.
Healthcare Shares

This ASX biotech's shares are up strongly on good news out of the US

The addressable market for this newly approved software is huge.

Read more »

Medical workers examine an xray or scan in a hospital laboratory.
Healthcare Shares

Which biotech company's shares have rocketed to a new high on good news?

A key US approval is great news for this company.

Read more »

Health professional working on his laptop.
Healthcare Shares

Insiders are buying. Can Pro Medicus shares finally turn the corner?

Insider buying puts Pro Medicus shares in focus after steep pullback, raising questions about downside risk and upside potential.

Read more »

a young boy in profile shows the cochlear implant devide fitted to his ear and attached to the side of his head to help him to process sounds.
Healthcare Shares

Cochlear shares lag the ASX 200 after a tough year. Is it time to buy?

Investors continue to question valuation and wait for stronger earnings momentum.

Read more »

A woman with strawberry blonde hair has a huge smile on her face and fist pumps the air having seen good news on her phone.
Healthcare Shares

Why are Mesoblast shares jumping 10% to a 52-week high?

This biotech is hitting new highs on Friday. Let's find out why.

Read more »

a group of surgeons in full surgery dress including masks, gloves and head coverings stands together with arms folded and smiling eyes as if happy with the outcome of their efforts.
Healthcare Shares

Ansell shares tumble to a 3-month low. Is this a buying opportunity?

Ansell shares have slid to a 3-month low. Could oversold signals point to a buying opportunity for long-term investors?

Read more »